Immix Biopharma, Inc. IMMX Lessee Operating Lease Liability Payments Due Year Four And Thereafter
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept IMMX:LesseeOperatingLeaseLiabilityPaymentsDueYearFourAndThereafter.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s lessee operating lease liability payments due year four and thereafter.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s lessee operating lease liability payments due year four and thereafter?
- Immix Biopharma, Inc. (IMMX) reported lessee operating lease liability payments due year four and thereafter of $564.34K in Q1 2026.
- How has Immix Biopharma, Inc.'s lessee operating lease liability payments due year four and thereafter changed year-over-year?
- Immix Biopharma, Inc.'s lessee operating lease liability payments due year four and thereafter decreased by 37.9% year-over-year, from $909.48K to $564.34K.